Xerafy is set to present its innovative smart RAIN RFID labeling solutions tailored for pharmaceutical and healthcare packaging at the AIPIA Innovation Stage during the CPHI South East Asia 2026. The event will be held in Bangkok, Thailand, from July 8 to 10, providing a platform to showcase cutting-edge technology designed to enhance various aspects of the healthcare supply chain.
The company’s range of RFID solutions aims to improve the traceability of medical devices, manage inventory more effectively, and boost visibility throughout the pharmaceutical supply chain. Among the featured products are the XSKIN Gamma, designed for gamma-sterilized packaging, the MICRO Medical, ideal for compact medical device identification, and the Metal Skin Delta, which is suited for on-metal healthcare assets and metallized packaging.
As the complexity of pharmaceutical supply chains continues to grow, smart RAIN RFID labels are proving invaluable. They facilitate item-level identification and enable real-time data capture across various stages, including manufacturing, sterilization, warehousing, distribution, and healthcare workflows. This technology significantly enhances product traceability, ensures inventory accuracy, and aids compliance by seamlessly linking physical products to their digital records.
Xerafy emphasizes that its RFID solutions are crafted for challenging environments where traditional barcode systems might fall short. These solutions are particularly effective in scenarios involving bulk handling, dense storage, and regulated healthcare applications. The company offers a comprehensive portfolio of specialized RFID labels and tags, catering not just to healthcare, but also to sectors such as manufacturing, logistics, aerospace, oil and gas, and data centers.
The upcoming showcase at CPHI South East Asia 2026 will provide a glimpse into how connected packaging and RFID technology can streamline pharmaceutical and medical device supply chains, promoting efficiency and accuracy throughout the process.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.